Clinical Observation of Qingying powder Intervention in Hashimoto thyroiditis with normal thyroid functio

Phase 1

• Conditions: Hashimoto thyroiditis

• Registration Number: ITMCTR2100005311
• Lead Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

? Comply with the diagnostic criteria of hashimoto's thyroiditis, TCM syndrome differentiation is liver spleen deficiency type;
? Adult patients aged 20 to 65 years, both male or female;
? Thyroid peroxidase antibody(TGAb) >300 IU/ml;
? Triiodothyronine(T3), thyroxine(T4),thyroid-stimulating hormone(TSH) were normal;
? Signing informed consent.

Exclusion Criteria

? Pregnant or lactating women;
? Anemia (male: hemoglobin<120g/L, female: hemoglobin<110g/L);
? Patients with autoimmune hepatitis, chronic glomerulonephritis and other autoimmune diseases;
? Patients received drugs that may affect the conversion of thyroxine to triiodothyronine, may affect thyroid autoimmune drug therapy including corticosteroid, amiodaron, propranolol, a-interferon, etc;
? Osteoporosis;
? Patients with mental illness.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
thyroid peroxidase antibody;thyroglobulin antibody;

Secondary Outcome Measures

Name	Time	Method
quality of life;TCM Symptom Score;thyroid volume;thyroid function;